Previous 10 | Next 10 |
Proteomics has the potential to revolutionize medicine in potentially the same way that genomics has. The traditional field looks primed for disruption and that effort could hit critical mass soon. Quantum-Si has set forth a business plan to utilize consumables as the primary driver o...
For many investors, genomics as a field is nothing new, albeit still exciting. But there's a new type of revolutionary science on the horizon, and a life sciences company called Seer (NASDAQ: SEER) that IPO'd in December thinks it holds the key to unlock this new frontier. In th...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead Tesla (NASDAQ:TSLA) holds a big event next week to showcase its new Model S Plaid, while the tech world will be watching...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
Seer, Inc. (SEER) Q1 2021 Earnings Conference Call May 10, 2021 04:30 PM ET Company Participants Carrie Mendivil - Investor Relations Omid Farokhzad - Chairman, Chief Executive Officer and Founder Omead Ostadan - President and Chief Operating Officer David Horn - Chief Financial Officer Confe...
Seer (SEER): Q1 Net loss was $16.4M for the first quarter of 2021, as compared to $5.5M for the corresponding prior year period.Revenue was $62,000, as compared to $177,000 for the three months ended March 31, 2020.Press Release For further details see: Seer reports Q1 results
Second Phase of Commercialization Advances with the Addition of Multiple Limited Release Customers REDWOOD CITY, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported fin...
REDWOOD CITY, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will be participating virtually in the upcoming BofA Securities 2021 Healthcare Conference. Seer ...
REDWOOD CITY, Calif., April 12, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financial results for the first quarter 2021 after market close on Monday, May 10, 2021. Comp...
Image source: The Motley Fool. Seer, Inc. (NASDAQ: SEER) Q4 2020 Earnings Call Mar 29, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Seer, Inc. (SEER) Q4 2020 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
REDWOOD CITY, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the second quarter 2024 on Thursday, August 8, 2024. Company manag...
Secretome profiles from SpaceX Inspiration4 mission show alterations in oxidative stress, brain homeostasis, and coagulation Creation of first-of-its-kind comprehensive atlas of molecular and physiological multiomic profiles available from multiple spaceflight missions REDWOOD CIT...
REDWOOD CITY, Calif., June 02, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, announced today that PrognomiQ has completed the largest and deepest unbiased mass spectrometry plasma biomarker study to da...